The global market for Subcutaneous Needle-free Injectors was valued at US$ 820 million in the year 2024 and is projected to reach a revised size of US$ 1618 million by 2031, growing at a CAGR of 10.2% during the forecast period.

Subcutaneous Needle-free Injectors Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Subcutaneous Needle-free Injectors competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Subcutaneous Needle-free Injector production reached approximately 6,406,250 units, with an average global market price of around US$ 128 per unit.

The gross profit margin of major companies in the industry is between 48% – 70%.

Single-line production capacity is 300,000 – 850,000 units/year.

Subcutaneous needle-free injectors are medical devices that deliver drugs through high-pressure jet technology without using traditional needles. They improve patient comfort, reduce needle-stick risks, and enhance compliance in vaccines, diabetes care, biologics delivery, and self-injection scenarios.

North American market for Subcutaneous Needle-free Injectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Subcutaneous Needle-free Injectors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Subcutaneous Needle-free Injectors include PharmaJet., Wirthwein Medical GmbH & Co KG, IntegriMedical Pvt Ltd., CROSSJECT, MIKA MEDICAL CO., Daicel Corporation, NuGen Medical Devices, Portal Instruments, Inc., Covestro AG, HealthD, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Needle-free Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Needle-free Injectors.

The Subcutaneous Needle-free Injectors market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Needle-free Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, by Injection Depth and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Subcutaneous Needle-free Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Injection Depth and by regions.

Scope of Subcutaneous Needle-free Injectors Market Report

Report Metric	Details
Report Name	Subcutaneous Needle-free Injectors Market
Accounted market size in year	US$ 820 million
Forecasted market size in 2031	US$ 1618 million
CAGR	10.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Gas-Driven Spring-Driven Electric-Driven Manual-Driven
Segment by Injection Depth	Intradermal Injector Subcutaneous Injector Intramuscular Injector
Segment by Usage Scenario	Clinical Medical Injector Household Vaccination Injector Veterinary Injector
Segment by Application	Hospitals Clinics Home Care Settings Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	PharmaJet., Wirthwein Medical GmbH & Co KG, IntegriMedical Pvt Ltd., CROSSJECT, MIKA MEDICAL CO., Daicel Corporation, NuGen Medical Devices, Portal Instruments, Inc., Covestro AG, HealthD, Medical International Technologies (MIT Canada) Inc., Ferring B.V., QUINOVARE & TECHiJET., Beijing QS Medical Technology Co.Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Needle-free Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Needle-free Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Subcutaneous Needle-free Injectors Market growing?

Ans: The Subcutaneous Needle-free Injectors Market witnessing a CAGR of 10.2% during the forecast period 2025-2031.

What is the Subcutaneous Needle-free Injectors Market size in 2031?

Ans: The Subcutaneous Needle-free Injectors Market size in 2031 will be US$ 1618 million.

Who are the main players in the Subcutaneous Needle-free Injectors Market report?

Ans: The main players in the Subcutaneous Needle-free Injectors Market are PharmaJet., Wirthwein Medical GmbH & Co KG, IntegriMedical Pvt Ltd., CROSSJECT, MIKA MEDICAL CO., Daicel Corporation, NuGen Medical Devices, Portal Instruments, Inc., Covestro AG, HealthD, Medical International Technologies (MIT Canada) Inc., Ferring B.V., QUINOVARE & TECHiJET., Beijing QS Medical Technology Co.Ltd

What are the Application segmentation covered in the Subcutaneous Needle-free Injectors Market report?

Ans: The Applications covered in the Subcutaneous Needle-free Injectors Market report are Hospitals, Clinics, Home Care Settings, Others

What are the Type segmentation covered in the Subcutaneous Needle-free Injectors Market report?

Ans: The Types covered in the Subcutaneous Needle-free Injectors Market report are Gas-Driven, Spring-Driven, Electric-Driven, Manual-Driven

1 Subcutaneous Needle-free Injectors Market Overview

1.1 Product Definition

1.2 Subcutaneous Needle-free Injectors by Type

1.2.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2024 VS 2031)

1.2.2 Gas-Driven

1.2.3 Spring-Driven

1.2.4 Electric-Driven

1.2.5 Manual-Driven

1.3 Subcutaneous Needle-free Injectors by Injection Depth

1.3.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Injection Depth: 2024 VS 2031

1.3.2 Intradermal Injector

1.3.3 Subcutaneous Injector

1.3.4 Intramuscular Injector

1.4 Subcutaneous Needle-free Injectors by Usage Scenario

1.4.1 Global Subcutaneous Needle-free Injectors Market Value Comparison by Usage Scenario: 2024 VS 2031

1.4.2 Clinical Medical Injector

1.4.3 Household Vaccination Injector

1.4.4 Veterinary Injector

1.5 Subcutaneous Needle-free Injectors by Application

1.5.1 Global Subcutaneous Needle-free Injectors Market Value by Application (2024 VS 2031)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Home Care Settings

1.5.5 Others

1.6 Global Subcutaneous Needle-free Injectors Market Size Estimates and Forecasts

1.6.1 Global Subcutaneous Needle-free Injectors Revenue 2020-2031

1.6.2 Global Subcutaneous Needle-free Injectors Sales 2020-2031

1.6.3 Global Subcutaneous Needle-free Injectors Market Average Price (2020-2031)

1.7 Assumptions and Limitations

2 Subcutaneous Needle-free Injectors Market Competition by Manufacturers

2.1 Global Subcutaneous Needle-free Injectors Sales Market Share by Manufacturers (2020-2025)

2.2 Global Subcutaneous Needle-free Injectors Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Subcutaneous Needle-free Injectors Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Subcutaneous Needle-free Injectors, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Product Type & Application

2.7 Global Key Manufacturers of Subcutaneous Needle-free Injectors, Date of Enter into This Industry

2.8 Global Subcutaneous Needle-free Injectors Market Competitive Situation and Trends

2.8.1 Global Subcutaneous Needle-free Injectors Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Subcutaneous Needle-free Injectors Players Market Share by Revenue

2.8.3 Global Subcutaneous Needle-free Injectors Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Subcutaneous Needle-free Injectors Market Scenario by Region

3.1 Global Subcutaneous Needle-free Injectors Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Subcutaneous Needle-free Injectors Sales by Region: 2020-2031

3.2.1 Global Subcutaneous Needle-free Injectors Sales by Region: 2020-2025

3.2.2 Global Subcutaneous Needle-free Injectors Sales by Region: 2026-2031

3.3 Global Subcutaneous Needle-free Injectors Revenue by Region: 2020-2031

3.3.1 Global Subcutaneous Needle-free Injectors Revenue by Region: 2020-2025

3.3.2 Global Subcutaneous Needle-free Injectors Revenue by Region: 2026-2031

3.4 North America Subcutaneous Needle-free Injectors Market Facts & Figures by Country

3.4.1 North America Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Subcutaneous Needle-free Injectors Sales by Country (2020-2031)

3.4.3 North America Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Subcutaneous Needle-free Injectors Market Facts & Figures by Country

3.5.1 Europe Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Subcutaneous Needle-free Injectors Sales by Country (2020-2031)

3.5.3 Europe Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Subcutaneous Needle-free Injectors Market Facts & Figures by Region

3.6.1 Asia Pacific Subcutaneous Needle-free Injectors Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2020-2031)

3.6.3 Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Subcutaneous Needle-free Injectors Market Facts & Figures by Country

3.7.1 Latin America Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Subcutaneous Needle-free Injectors Sales by Country (2020-2031)

3.7.3 Latin America Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Subcutaneous Needle-free Injectors Market Facts & Figures by Country

3.8.1 Middle East and Africa Subcutaneous Needle-free Injectors Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2020-2031)

3.8.3 Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Subcutaneous Needle-free Injectors Sales by Type (2020-2031)

4.1.1 Global Subcutaneous Needle-free Injectors Sales by Type (2020-2025)

4.1.2 Global Subcutaneous Needle-free Injectors Sales by Type (2026-2031)

4.1.3 Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2020-2031)

4.2 Global Subcutaneous Needle-free Injectors Revenue by Type (2020-2031)

4.2.1 Global Subcutaneous Needle-free Injectors Revenue by Type (2020-2025)

4.2.2 Global Subcutaneous Needle-free Injectors Revenue by Type (2026-2031)

4.2.3 Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2020-2031)

4.3 Global Subcutaneous Needle-free Injectors Price by Type (2020-2031)

5 Segment by Application

5.1 Global Subcutaneous Needle-free Injectors Sales by Application (2020-2031)

5.1.1 Global Subcutaneous Needle-free Injectors Sales by Application (2020-2025)

5.1.2 Global Subcutaneous Needle-free Injectors Sales by Application (2026-2031)

5.1.3 Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2020-2031)

5.2 Global Subcutaneous Needle-free Injectors Revenue by Application (2020-2031)

5.2.1 Global Subcutaneous Needle-free Injectors Revenue by Application (2020-2025)

5.2.2 Global Subcutaneous Needle-free Injectors Revenue by Application (2026-2031)

5.2.3 Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2020-2031)

5.3 Global Subcutaneous Needle-free Injectors Price by Application (2020-2031)

6 Key Companies Profiled

6.1 PharmaJet.

6.1.1 PharmaJet. Company Information

6.1.2 PharmaJet. Description and Business Overview

6.1.3 PharmaJet. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.1.4 PharmaJet. Subcutaneous Needle-free Injectors Product Portfolio

6.1.5 PharmaJet. Recent Developments/Updates

6.2 Wirthwein Medical GmbH & Co KG

6.2.1 Wirthwein Medical GmbH & Co KG Company Information

6.2.2 Wirthwein Medical GmbH & Co KG Description and Business Overview

6.2.3 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Product Portfolio

6.2.5 Wirthwein Medical GmbH & Co KG Recent Developments/Updates

6.3 IntegriMedical Pvt Ltd.

6.3.1 IntegriMedical Pvt Ltd. Company Information

6.3.2 IntegriMedical Pvt Ltd. Description and Business Overview

6.3.3 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.3.4 IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Product Portfolio

6.3.5 IntegriMedical Pvt Ltd. Recent Developments/Updates

6.4 CROSSJECT

6.4.1 CROSSJECT Company Information

6.4.2 CROSSJECT Description and Business Overview

6.4.3 CROSSJECT Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.4.4 CROSSJECT Subcutaneous Needle-free Injectors Product Portfolio

6.4.5 CROSSJECT Recent Developments/Updates

6.5 MIKA MEDICAL CO.

6.5.1 MIKA MEDICAL CO. Company Information

6.5.2 MIKA MEDICAL CO. Description and Business Overview

6.5.3 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.5.4 MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Product Portfolio

6.5.5 MIKA MEDICAL CO. Recent Developments/Updates

6.6 Daicel Corporation

6.6.1 Daicel Corporation Company Information

6.6.2 Daicel Corporation Description and Business Overview

6.6.3 Daicel Corporation Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Daicel Corporation Subcutaneous Needle-free Injectors Product Portfolio

6.6.5 Daicel Corporation Recent Developments/Updates

6.7 NuGen Medical Devices

6.7.1 NuGen Medical Devices Company Information

6.7.2 NuGen Medical Devices Description and Business Overview

6.7.3 NuGen Medical Devices Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.7.4 NuGen Medical Devices Subcutaneous Needle-free Injectors Product Portfolio

6.7.5 NuGen Medical Devices Recent Developments/Updates

6.8 Portal Instruments, Inc.

6.8.1 Portal Instruments, Inc. Company Information

6.8.2 Portal Instruments, Inc. Description and Business Overview

6.8.3 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Portal Instruments, Inc. Subcutaneous Needle-free Injectors Product Portfolio

6.8.5 Portal Instruments, Inc. Recent Developments/Updates

6.9 Covestro AG

6.9.1 Covestro AG Company Information

6.9.2 Covestro AG Description and Business Overview

6.9.3 Covestro AG Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Covestro AG Subcutaneous Needle-free Injectors Product Portfolio

6.9.5 Covestro AG Recent Developments/Updates

6.10 HealthD

6.10.1 HealthD Company Information

6.10.2 HealthD Description and Business Overview

6.10.3 HealthD Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.10.4 HealthD Subcutaneous Needle-free Injectors Product Portfolio

6.10.5 HealthD Recent Developments/Updates

6.11 Medical International Technologies (MIT Canada) Inc.

6.11.1 Medical International Technologies (MIT Canada) Inc. Company Information

6.11.2 Medical International Technologies (MIT Canada) Inc. Description and Business Overview

6.11.3 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Product Portfolio

6.11.5 Medical International Technologies (MIT Canada) Inc. Recent Developments/Updates

6.12 Ferring B.V.

6.12.1 Ferring B.V. Company Information

6.12.2 Ferring B.V. Description and Business Overview

6.12.3 Ferring B.V. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Ferring B.V. Subcutaneous Needle-free Injectors Product Portfolio

6.12.5 Ferring B.V. Recent Developments/Updates

6.13 QUINOVARE & TECHiJET.

6.13.1 QUINOVARE & TECHiJET. Company Information

6.13.2 QUINOVARE & TECHiJET. Description and Business Overview

6.13.3 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.13.4 QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Product Portfolio

6.13.5 QUINOVARE & TECHiJET. Recent Developments/Updates

6.14 Beijing QS Medical Technology Co.Ltd

6.14.1 Beijing QS Medical Technology Co.Ltd Company Information

6.14.2 Beijing QS Medical Technology Co.Ltd Description and Business Overview

6.14.3 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Product Portfolio

6.14.5 Beijing QS Medical Technology Co.Ltd Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Subcutaneous Needle-free Injectors Industry Chain Analysis

7.2 Subcutaneous Needle-free Injectors Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Subcutaneous Needle-free Injectors Production Mode & Process Analysis

7.4 Subcutaneous Needle-free Injectors Sales and Marketing

7.4.1 Subcutaneous Needle-free Injectors Sales Channels

7.4.2 Subcutaneous Needle-free Injectors Distributors

7.5 Subcutaneous Needle-free Injectors Customer Analysis

8 Subcutaneous Needle-free Injectors Market Dynamics

8.1 Subcutaneous Needle-free Injectors Industry Trends

8.2 Subcutaneous Needle-free Injectors Market Drivers

8.3 Subcutaneous Needle-free Injectors Market Challenges

8.4 Subcutaneous Needle-free Injectors Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Companies

PharmaJet

Wirthwein Medical GmbH & Co KG

NuGen Medical Devices

Portal Instruments, Inc.

Covestro AG

HealthD

Medical International Technologies (MIT Canada) Inc.

Ferring B.V.

QUINOVARE & TECHiJET.

Beijing QS Medical Technology Co.Ltd

List of Tables

Table 1. Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Subcutaneous Needle-free Injectors Market Value by Injection Depth, (US$ Million) & (2024 VS 2031)

Table 3. Global Subcutaneous Needle-free Injectors Market Value by Usage Scenario, (US$ Million) & (2024 VS 2031)

Table 4. Global Subcutaneous Needle-free Injectors Market Value by Application (2024 VS 2031) & (US$ Million)

Table 5. Global Subcutaneous Needle-free Injectors Market Competitive Situation by Manufacturers in 2024

Table 6. Global Subcutaneous Needle-free Injectors Sales (Units) of Key Manufacturers (2020-2025)

Table 7. Global Subcutaneous Needle-free Injectors Sales Market Share by Manufacturers (2020-2025)

Table 8. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Manufacturers (2020-2025)

Table 9. Global Subcutaneous Needle-free Injectors Revenue Share by Manufacturers (2020-2025)

Table 10. Global Market Subcutaneous Needle-free Injectors Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 11. Global Key Players of Subcutaneous Needle-free Injectors, Industry Ranking, 2022 VS 2023 VS 2024

Table 12. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Manufacturing Sites & Headquarters

Table 13. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Product Type & Application

Table 14. Global Key Manufacturers of Subcutaneous Needle-free Injectors, Date of Enter into This Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Subcutaneous Needle-free Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Needle-free Injectors as of 2024)

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Subcutaneous Needle-free Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Subcutaneous Needle-free Injectors Sales by Region (2020-2025) & (Units)

Table 20. Global Subcutaneous Needle-free Injectors Sales Market Share by Region (2020-2025)

Table 21. Global Subcutaneous Needle-free Injectors Sales by Region (2026-2031) & (Units)

Table 22. Global Subcutaneous Needle-free Injectors Sales Market Share by Region (2026-2031)

Table 23. Global Subcutaneous Needle-free Injectors Revenue by Region (2020-2025) & (US$ Million)

Table 24. Global Subcutaneous Needle-free Injectors Revenue Market Share by Region (2020-2025)

Table 25. Global Subcutaneous Needle-free Injectors Revenue by Region (2026-2031) & (US$ Million)

Table 26. Global Subcutaneous Needle-free Injectors Revenue Market Share by Region (2026-2031)

Table 27. North America Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. North America Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)

Table 29. North America Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)

Table 30. North America Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)

Table 31. North America Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)

Table 32. Europe Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 33. Europe Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)

Table 34. Europe Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)

Table 35. Europe Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)

Table 36. Europe Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)

Table 37. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 38. Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2020-2025) & (Units)

Table 39. Asia Pacific Subcutaneous Needle-free Injectors Sales by Region (2026-2031) & (Units)

Table 40. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2020-2025) & (US$ Million)

Table 41. Asia Pacific Subcutaneous Needle-free Injectors Revenue by Region (2026-2031) & (US$ Million)

Table 42. Latin America Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Latin America Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)

Table 44. Latin America Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)

Table 45. Latin America Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)

Table 46. Latin America Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)

Table 47. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 48. Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2020-2025) & (Units)

Table 49. Middle East and Africa Subcutaneous Needle-free Injectors Sales by Country (2026-2031) & (Units)

Table 50. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2020-2025) & (US$ Million)

Table 51. Middle East and Africa Subcutaneous Needle-free Injectors Revenue by Country (2026-2031) & (US$ Million)

Table 52. Global Subcutaneous Needle-free Injectors Sales (Units) by Type (2020-2025)

Table 53. Global Subcutaneous Needle-free Injectors Sales (Units) by Type (2026-2031)

Table 54. Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2020-2025)

Table 55. Global Subcutaneous Needle-free Injectors Sales Market Share by Type (2026-2031)

Table 56. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Type (2020-2025)

Table 57. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Type (2026-2031)

Table 58. Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2020-2025)

Table 59. Global Subcutaneous Needle-free Injectors Revenue Market Share by Type (2026-2031)

Table 60. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2020-2025)

Table 61. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2026-2031)

Table 62. Global Subcutaneous Needle-free Injectors Sales (Units) by Application (2020-2025)

Table 63. Global Subcutaneous Needle-free Injectors Sales (Units) by Application (2026-2031)

Table 64. Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2020-2025)

Table 65. Global Subcutaneous Needle-free Injectors Sales Market Share by Application (2026-2031)

Table 66. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Application (2020-2025)

Table 67. Global Subcutaneous Needle-free Injectors Revenue (US$ Million) by Application (2026-2031)

Table 68. Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2020-2025)

Table 69. Global Subcutaneous Needle-free Injectors Revenue Market Share by Application (2026-2031)

Table 70. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2020-2025)

Table 71. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2026-2031)

Table 72. PharmaJet. Company Information

Table 73. PharmaJet. Description and Business Overview

Table 74. PharmaJet. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. PharmaJet. Subcutaneous Needle-free Injectors Product

Table 76. PharmaJet. Recent Developments/Updates

Table 77. Wirthwein Medical GmbH & Co KG Company Information

Table 78. Wirthwein Medical GmbH & Co KG Description and Business Overview

Table 79. Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Wirthwein Medical GmbH & Co KG Subcutaneous Needle-free Injectors Product

Table 81. Wirthwein Medical GmbH & Co KG Recent Developments/Updates

Table 82. IntegriMedical Pvt Ltd. Company Information

Table 83. IntegriMedical Pvt Ltd. Description and Business Overview

Table 84. IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. IntegriMedical Pvt Ltd. Subcutaneous Needle-free Injectors Product

Table 86. IntegriMedical Pvt Ltd. Recent Developments/Updates

Table 87. CROSSJECT Company Information

Table 88. CROSSJECT Description and Business Overview

Table 89. CROSSJECT Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. CROSSJECT Subcutaneous Needle-free Injectors Product

Table 91. CROSSJECT Recent Developments/Updates

Table 92. MIKA MEDICAL CO. Company Information

Table 93. MIKA MEDICAL CO. Description and Business Overview

Table 94. MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. MIKA MEDICAL CO. Subcutaneous Needle-free Injectors Product

Table 96. MIKA MEDICAL CO. Recent Developments/Updates

Table 97. Daicel Corporation Company Information

Table 98. Daicel Corporation Description and Business Overview

Table 99. Daicel Corporation Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Daicel Corporation Subcutaneous Needle-free Injectors Product

Table 101. Daicel Corporation Recent Developments/Updates

Table 102. NuGen Medical Devices Company Information

Table 103. NuGen Medical Devices Description and Business Overview

Table 104. NuGen Medical Devices Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. NuGen Medical Devices Subcutaneous Needle-free Injectors Product

Table 106. NuGen Medical Devices Recent Developments/Updates

Table 107. Portal Instruments, Inc. Company Information

Table 108. Portal Instruments, Inc. Description and Business Overview

Table 109. Portal Instruments, Inc. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Portal Instruments, Inc. Subcutaneous Needle-free Injectors Product

Table 111. Portal Instruments, Inc. Recent Developments/Updates

Table 112. Covestro AG Company Information

Table 113. Covestro AG Description and Business Overview

Table 114. Covestro AG Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Covestro AG Subcutaneous Needle-free Injectors Product

Table 116. Covestro AG Recent Developments/Updates

Table 117. HealthD Company Information

Table 118. HealthD Description and Business Overview

Table 119. HealthD Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. HealthD Subcutaneous Needle-free Injectors Product

Table 121. HealthD Recent Developments/Updates

Table 122. Medical International Technologies (MIT Canada) Inc. Company Information

Table 123. Medical International Technologies (MIT Canada) Inc. Description and Business Overview

Table 124. Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. Medical International Technologies (MIT Canada) Inc. Subcutaneous Needle-free Injectors Product

Table 126. Medical International Technologies (MIT Canada) Inc. Recent Developments/Updates

Table 127. Ferring B.V. Company Information

Table 128. Ferring B.V. Description and Business Overview

Table 129. Ferring B.V. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 130. Ferring B.V. Subcutaneous Needle-free Injectors Product

Table 131. Ferring B.V. Recent Developments/Updates

Table 132. QUINOVARE & TECHiJET. Company Information

Table 133. QUINOVARE & TECHiJET. Description and Business Overview

Table 134. QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 135. QUINOVARE & TECHiJET. Subcutaneous Needle-free Injectors Product

Table 136. QUINOVARE & TECHiJET. Recent Developments/Updates

Table 137. Beijing QS Medical Technology Co.Ltd Company Information

Table 138. Beijing QS Medical Technology Co.Ltd Description and Business Overview

Table 139. Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 140. Beijing QS Medical Technology Co.Ltd Subcutaneous Needle-free Injectors Product

Table 141. Beijing QS Medical Technology Co.Ltd Recent Developments/Updates

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Subcutaneous Needle-free Injectors Distributors List

Table 145. Subcutaneous Needle-free Injectors Customers List

Table 146. Subcutaneous Needle-free Injectors Market Trends

Table 147. Subcutaneous Needle-free Injectors Market Drivers

Table 148. Subcutaneous Needle-free Injectors Market Challenges

Table 149. Subcutaneous Needle-free Injectors Market Restraints

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

Table 153. Authors List of This Report

List of Figures

Figure 1. Product Picture of Subcutaneous Needle-free Injectors

Figure 2. Global Subcutaneous Needle-free Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Subcutaneous Needle-free Injectors Market Share by Type: 2024 & 2031

Figure 4. Gas-Driven Product Picture

Figure 5. Spring-Driven Product Picture

Figure 6. Electric-Driven Product Picture

Figure 7. Manual-Driven Product Picture

Figure 8. Global Subcutaneous Needle-free Injectors Market Value by Injection Depth, (US$ Million) & (2020-2031)

Figure 9. Global Subcutaneous Needle-free Injectors Market Share by Injection Depth: 2024 VS 2031

Figure 10. Intradermal Injector Product Picture

Figure 11. Subcutaneous Injector Product Picture

Figure 12. Intramuscular Injector Product Picture

Figure 13. Global Subcutaneous Needle-free Injectors Market Value by Usage Scenario, (US$ Million) & (2020-2031)

Figure 14. Global Subcutaneous Needle-free Injectors Market Share by Usage Scenario: 2024 VS 2031

Figure 15. Clinical Medical Injector Product Picture

Figure 16. Household Vaccination Injector Product Picture

Figure 17. Veterinary Injector Product Picture

Figure 18. Global Subcutaneous Needle-free Injectors Market Value by Application (2020-2031) & (US$ Million)

Figure 19. Global Subcutaneous Needle-free Injectors Market Share by Application: 2024 & 2031

Figure 20. Hospitals

Figure 21. Clinics

Figure 22. Home Care Settings

Figure 23. Others

Figure 24. Global Subcutaneous Needle-free Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 25. Global Subcutaneous Needle-free Injectors Market Size (2020-2031) & (US$ Million)

Figure 26. Global Subcutaneous Needle-free Injectors Sales (2020-2031) & (Units)

Figure 27. Global Subcutaneous Needle-free Injectors Average Price (US$/Unit) & (2020-2031)

Figure 28. Subcutaneous Needle-free Injectors Report Years Considered

Figure 29. Subcutaneous Needle-free Injectors Sales Share by Manufacturers in 2024

Figure 30. Global Subcutaneous Needle-free Injectors Revenue Share by Manufacturers in 2024

Figure 31. Global 5 and 10 Largest Subcutaneous Needle-free Injectors Players: Market Share by Revenue in Subcutaneous Needle-free Injectors in 2024

Figure 32. Subcutaneous Needle-free Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 33. Global Subcutaneous Needle-free Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 34. North America Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)

Figure 35. North America Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)

Figure 36. United States Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Canada Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Europe Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)

Figure 39. Europe Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)

Figure 40. Germany Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. France Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. U.K. Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Italy Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Russia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Asia Pacific Subcutaneous Needle-free Injectors Sales Market Share by Region (2020-2031)

Figure 46. Asia Pacific Subcutaneous Needle-free Injectors Revenue Market Share by Region (2020-2031)

Figure 47. China Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Japan Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. South Korea Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. India Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Australia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. China Taiwan Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Southeast Asia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Latin America Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)

Figure 55. Latin America Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)

Figure 56. Mexico Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Brazil Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Argentina Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Colombia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Middle East and Africa Subcutaneous Needle-free Injectors Sales Market Share by Country (2020-2031)

Figure 61. Middle East and Africa Subcutaneous Needle-free Injectors Revenue Market Share by Country (2020-2031)

Figure 62. Turkey Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 63. Saudi Arabia Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 64. UAE Subcutaneous Needle-free Injectors Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 65. Global Sales Market Share of Subcutaneous Needle-free Injectors by Type (2020-2031)

Figure 66. Global Revenue Market Share of Subcutaneous Needle-free Injectors by Type (2020-2031)

Figure 67. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Type (2020-2031)

Figure 68. Global Sales Market Share of Subcutaneous Needle-free Injectors by Application (2020-2031)

Figure 69. Global Revenue Market Share of Subcutaneous Needle-free Injectors by Application (2020-2031)

Figure 70. Global Subcutaneous Needle-free Injectors Price (US$/Unit) by Application (2020-2031)

Figure 71. Subcutaneous Needle-free Injectors Value Chain

Figure 72. Channels of Distribution (Direct Vs Distribution)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-6S20317

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Off-The-Road Tyre [Off-The-Road Tire] Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16K20174

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Automotive Parts Electrophoretic Paint Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39H19971

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Automotive Body Electrophoretic Paint Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28K19901

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Subcutaneous Needle-free Injectors Market Research Report 2025

Published Date: November 2025

Report Code: QYRE-Auto-3Z20235

Global Subcutaneous Needle-free Injectors Market Research Report 2025

FEATURED COMPANIES

Subcutaneous Needle-free Injectors Market Size

Subcutaneous Needle-free Injectors Market

Report Scope

Scope of Subcutaneous Needle-free Injectors Market Report

Core Chapters

FAQ for this report

How fast is Subcutaneous Needle-free Injectors Market growing?

What is the Subcutaneous Needle-free Injectors Market size in 2031?

Who are the main players in the Subcutaneous Needle-free Injectors Market report?

What are the Application segmentation covered in the Subcutaneous Needle-free Injectors Market report?

What are the Type segmentation covered in the Subcutaneous Needle-free Injectors Market report?

FEATURED COMPANIES

RELATED REPORTS